MARKET

AMGN

AMGN

Amgen Inc
NASDAQ
289.18
+4.00
+1.40%
After Hours: 289.18 0 0.00% 19:51 02/23 EST
OPEN
286.52
PREV CLOSE
285.18
HIGH
292.24
LOW
286.01
VOLUME
2.46M
TURNOVER
0
52 WEEK HIGH
329.72
52 WEEK LOW
206.75
MARKET CAP
154.98B
P/E (TTM)
23.16
1D
5D
1M
3M
1Y
5Y
Amgen (AMGN) Price Target Increased by 6.83% to 313.74
NASDAQ · 2d ago
Dow Movers: BA, AMGN
NASDAQ · 2d ago
Validea Detailed Fundamental Analysis - AMGN
NASDAQ · 2d ago
Amgen, Goldman Sachs share gains lead Dow's 125-point jump
The Dow Jones Industrial Average is up 128 points, or 0.3%, Friday morning. Shares of Amgen and Goldman Sachs are leading the way for the index's intraday rally. American Express, Microsoft and JPMorgan Chase are also contributing to the gain. The index is up 41 points for the day.
MarketWatch · 2d ago
Buy Rating Affirmed: Growth and Expansion in Amgen’s Rare Disease Portfolio Post-Horizon Acquisition
TipRanks · 2d ago
Amgen’s Strategic Growth and Market Expansion in Rare Diseases Bolster Buy Rating
TipRanks · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Alnylam Pharma (ALNY) and Bausch Health Companies (BHC)
TipRanks · 2d ago
Barclays Sticks to Their Sell Rating for Amgen (AMGN)
TipRanks · 2d ago
More
About AMGN
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq), Evenity, LumaKras, Nplate, XGeva, and others. The Company focuses on human therapeutics for the treatment of serious illness. It also offers TEPEZZA (teprotumumab-trbw), KRYSTEXXA (pegloticase) and UPLIZNA (inebilizumab-cdon).

Webull offers Amgen Inc stock information, including NASDAQ: AMGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMGN stock methods without spending real money on the virtual paper trading platform.